DOI: http://dx.doi.org/10.18203/issn.2454-5929.ijohns20193587

Prevalence of external and internal lymphedema secondary to head and neck cancer treatment

Deep Jyoti Manhas, Aditya Saraf, Arti .

Abstract


Background: Patients of head and neck cancer are at risk of developing secondary lymphedema after being treated for head and cancer. The purpose of this study was to examine the prevalence of secondary head and neck (HNL) lymphedema in post treated patients of head and neck cancer (HNC).

Methods: This was a prospective observational study including 48 head and neck cancer patients who were atleast 3 months post treatment. The present study was conducted in the department of ENT, GMC Jammu for a period of 1 year from February 2018 to March 2019.

Results: Forty patients (43.34%)  were males and 8 were females with age ranging from 25 to 82 years. 58.33% patients in our study had some form of lymphedema. Out of these patients, 21.43% had only external lymphedema, 35.71% had only internal lymphedema and 42.86% had combined lymphedema.

Conclusions: Lymphedema should be examined in the patients with head and neck cancer patients.


Keywords


Lymphedema, Head and neck, Cancer, Prevalence

Full Text:

PDF

References


Deng J, Murphy BA, Wells N, Wallston KA, Sinard RJ, Ridner SH, et al. Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status and quality of life. Head Neck. 2013;35(7):1026-35.

Dietz A, Rudat V, Nullert J, Helbig M, Vanselow B, Weidauer H. Chronic laryngeal edema as a late reaction to radio-chemotherapy. HNO. 1998;46(8):731-8.

Buntzel J, Glatzel M, Mucke R, Micke O, Burns F. Influrnce of amifostine therapy on late radiation- toxicity in head and neck cancer- a follow up study. Anticancer Res. 2007;27(4):1953-6.

Schiefke F, Akdemir M, Weber A, Akdemir D, Singer S, Frerich B. Functional postoperative morbidity and quality of life after cervical sentinel node biopsy and after selective neck dissection. Head Neck. 2009;31(4):503-12.

Deng J, Ridner SH, Dietrich MS, Wells N, Wallston KA, Sinard RJ, et al. Prevalence of secondary lymphedema in patients with head and neck cancer. J Pain Symptom Manage. 2012;43(2):244-52.

Smith BG, Lewin, Jan S. Lymphedema management in head and neck cancer. Current Opinion in Otolaryngol Head Neck Surg. 2010;18(3):153-8.

American Cancer Society, Donaldson S. Lymphedema: Understanding and managing lymphedema after cancer treatment. 1st ed. Atlanta, GA: Am Cancer Society; 2006.

Deng J, Ridner SH, Murphy BA. Lymphedema in Patients with Head and Neck Cancer. Oncol Nurs Forum. 2011;38(1):1-10.

Patterson JM, Hilderth A, Wilson JA. Measuring edema in irradiated head and neck cancer patients. Ann Otol Rhinol Laryngol. 2007;116(8):559-64.

Wolff HA, Overbeck T, Roedel RM, Hermann RM, Hermann MK, Kertesez T, et al. Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer. J Cancer Res Clin Oncol. 2009;135(7):961-7.